Form 4 for SONM DNA X, Inc.
Accepted 2023-12-28 00:00:00 ET · period of report 2023-12-26 · accession 0001493152-23-046419 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-28 | 2023-12-26 | SONM | Becher Charles | See Remarks | M - OptEx | $0.42 | +125.0K | 233.2K | +115% | +$52.5K |
| D | 2023-12-28 | 2023-12-26 | SONM | Becher Charles | See Remarks | M - OptEx | $0.00 | -125.0K | 275.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-26 | M | A | 125,000 | $0.42 | 233,227 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-12-26 | M | D | 125,000 | $0.00 | 275,000 | D | $0.42 · — to 2032-08-29 | 125,000 Common Stock | (F1) The options will vest in eleven (11) equal quarterly installments from February 29, 2024 to August 29, 2026. The options become exercisable upon vesting. |